# Jade Biosciences, Inc.: Form 8-K, filed May 1, 2025

- Company: [Jade Biosciences, Inc.](/companies/jbio.md) (CIK 1798749)
- Form: 8-K
- Filed: 2025-05-01
- Accepted by EDGAR: May 1, 2025, 16:22 ET
- Period: 2025-04-28
- Accession: 0001193125-25-110004
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1798749/000119312525110004/d847557d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1798749/000119312525110004/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.01: Completion of an acquisition or disposition
- Item 2.02: Results of operations
- Item 3.03: Change to security holders’ rights
- Item 4.01: Change of auditor
- Item 5.01: Change in control
- Item 5.02: Departure or appointment of officers or directors
- Item 5.03: Amendment to articles or bylaws
- Item 5.05: Item not in the standard list
- Item 5.06: Item not in the standard list
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1798749/000119312525110004/d847557d8k.htm

Filed May 1, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-110004. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.